Of course, more studies are needed to confirm or deny this possibility, but current research is encouraging
Phillips RS, Iradukunda EC, Hughes T, Bowen JP (2019) Modulation of enzyme activity in the kynurenine pathway by kynurenine monooxygenase inhibition
They want to know which option is real, which is safer to start now, and whether it is worth waiting for a drug that is still being studied
ICHRA & Finding a Plan with GLP-1 Coverage Small businesses that want an affordable, flexible option for providing health care benefits can use ICHRA to get the best of both worlds
In psoriasis, GLP-1 RAs, particularly liraglutide, have been associated with improvements in the Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI), especially among patients with T2D